However, there was no established biomarker threshold at which FC could be considered significant, and to date, hs‐cTn and NT‐proBNP measurement has primarily played a supportive role to cMRI for monitoring established FC.
← all excerpts
The Utility of High-Sensitivity Troponin to Detect Cardiomyopathy in Patients With Fabry Disease.
1
—
—